Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Arabia · Delayed Price · Currency is SAR

29.98

+0.68 (2.32%)

Apr 14, 2026, 1:05 PM AST

TADAWUL:2070 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,707	1,682	1,655	1,422	1,460
Revenue Growth (YoY)	1.47%	1.60%	16.43%	-2.60%	-6.14%
Cost of Revenue	886.06	865.95	965.8	864.5	846.73
Gross Profit	820.65	816.05	689.64	557.31	613.05
Selling, General & Admin	521.41	592.49	615.47	620.63	551.26
Research & Development	60.48	76.39	41.8	42.65	29.07
Other Operating Expenses	-9.14	-4.44	-69.39	-7.93	13.74
Operating Expenses	594.05	701.49	629.92	665.39	580.22
Operating Income	226.6	114.56	59.72	-108.08	32.83
Interest Expense	-89.03	-86.77	-63.51	-34.33	-31.4
Interest & Investment Income	13.2	7.66	10.59	-	-
Earnings From Equity Investments	24.35	22.73	20	20.44	11.41
Currency Exchange Gain (Loss)	3.46	-10.16	-4.32	-14.38	15.03
Other Non Operating Income (Expenses)	-	-	-3.17	-	-1.49
EBT Excluding Unusual Items	178.59	48.02	19.3	-136.35	26.38
Gain (Loss) on Sale of Investments	-	-	-	3.63	7.81
Gain (Loss) on Sale of Assets	28.7	18.94	6.38	0.14	-0.45
Legal Settlements	-1.64	5.05	-20.47	-	-
Pretax Income	205.65	72.01	5.21	-132.59	33.73
Income Tax Expense	8.84	40.17	45.26	25.9	12.35
Earnings From Continuing Operations	196.81	31.84	-40.05	-158.48	21.38
Earnings From Discontinued Operations	-	-	-	-12.75	-3.28
Net Income to Company	196.81	31.84	-40.05	-171.23	18.1
Minority Interest in Earnings	-12.45	-7.31	-10.68	6.1	8.35
Net Income	184.36	24.54	-50.73	-165.14	26.45
Net Income to Common	184.36	24.54	-50.73	-165.14	26.45
Net Income Growth	651.43%	-	-	-	-78.80%
Shares Outstanding (Basic)	119	120	120	120	120
Shares Outstanding (Diluted)	119	120	120	120	120
Shares Change (YoY)	-0.15%	-0.08%	-0.31%	-	-
EPS (Basic)	1.54	0.21	-0.42	-1.38	0.22
EPS (Diluted)	1.54	0.21	-0.42	-1.38	0.22
EPS Growth	652.54%	-	-	-	-78.80%
Free Cash Flow	183.21	-402.23	-95.92	-177.51	10.47
Free Cash Flow Per Share	1.53	-3.37	-0.80	-1.48	0.09
Dividend Per Share	0.350	-	-	-	0.600
Dividend Growth	-	-	-	-	-40.00%
Gross Margin	48.08%	48.52%	41.66%	39.20%	42.00%
Operating Margin	13.28%	6.81%	3.61%	-7.60%	2.25%
Profit Margin	10.80%	1.46%	-3.06%	-11.61%	1.81%
Free Cash Flow Margin	10.73%	-23.91%	-5.79%	-12.48%	0.72%
EBITDA	305.4	189.52	131.34	-28.21	112.57
EBITDA Margin	17.89%	11.27%	7.93%	-1.98%	7.71%
D&A For EBITDA	78.8	74.96	71.62	79.87	79.74
EBIT	226.6	114.56	59.72	-108.08	32.83
EBIT Margin	13.28%	6.81%	3.61%	-7.60%	2.25%
Effective Tax Rate	4.30%	55.78%	868.21%	-	36.60%
Advertising Expenses	39.67	33.2	56.75	41.89	40.43

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.